Geneva, May 28 -- International Clinical Trials Registry received information related to the study (ISRCTN82430224) titled 'Exploring the safety and practicality of strobe light therapy for depression' on May 1.
Study Type: Other
Study Design:
Single-arm safety and tolerability study (with dose escalation) (Safety)
Primary Sponsor: University of Sussex
Condition:
Depression
Mental and Behavioural Disorders
Intervention:
This tolerability study will not have a control condition.
Participants will complete an online safety questionnaire for pre-screening to minimise the risk of seizures from strobe light and screen for depression. Participants will be invited into the laboratory for testing, completing 11 2-minute strobe session...